In short. Modest improvement in texture and firmness is what the record reports. What the studies measured, how long they followed patients, and where the evidence is thin.

Key points

  • Some improvement in the appearance of the surface, reported by patients and by assessors looking at photographs, at a follow-up measured in months.
  • That is the shape of the average result.
  • It is a modest change in texture and firmness rather than a change in the contour of the face, and any honest reading of the literature starts there.

What follows is a summary of the published record, stated in general terms. This review does not cite individual studies and does not name devices, because the differences between devices are the substance of the question.

What the record consistently reports

The most reliable finding is a change in the surface of the skin. Treated skin is commonly reported as smoother, with fewer fine lines and more even tone. Histological work shows that the treatment injures the skin and that new collagen forms during healing, which is what the mechanism predicts.

What a result looks like in a study

Some improvement in the appearance of the surface, reported by patients and by assessors looking at photographs, at a follow-up measured in months. That is the shape of the average result. It is a modest change in texture and firmness rather than a change in the contour of the face, and any honest reading of the literature starts there.

How thin the record is

The studies are few and small. Sample sizes are typically in the tens rather than the hundreds. Devices and settings are not standardised, so a study of one instrument does not describe another. Follow-up is usually months rather than years, which leaves durability largely unmeasured. Outcomes are often judged from photographs, sometimes by the treating clinician, which is weak evidence. And much of the published work is supported by the makers of the devices being studied, which does not make it false but does mean it should not be the only input.

Where the grades come from

This is why the decision table on the home page separates the established claims from the limited ones. That plasma creates a controlled surface injury, and that the tightening it produces is modest rather than a lift, are established: the first is what the treatment is, and the second is what the literature reports. That new collagen forms, and that improvement continues for months, are graded limited — both are consistent with the mechanism and neither is established well enough to carry a plan. That it replaces a facelift, or tightens a whole face in one session, is not supported at all.

What the evidence does not settle

It does not settle how long a result lasts, or whether one device or setting is better than another, because head-to-head comparisons are largely absent. It does not settle how much of the reported improvement is the treatment rather than the healing, the topical care that accompanies it, or the patient's own expectation. And it does not settle the pigment question, which decides whether the treatment is suitable at all.

Seek care if

  • Blistering, spreading redness, warmth or pus in a treated area — that suggests infection and needs assessment.
  • A wound that is not closing on the expected course, or pain that worsens after the first days rather than settling.
  • A treated area that heals darker or lighter than the surrounding skin — have it assessed rather than treated again.

Related reading

Frequently asked questions

What does the evidence actually show for plasma tightening?

A modest improvement in the surface of the skin: smoother texture, fewer fine lines, more even tone, and some improvement in firmness reported by patients and by assessors looking at photographs. New collagen is measurable in biopsy studies. What is not shown is a change in the position of the face, and durability is largely unmeasured.

How long were patients followed in these studies?

Usually months rather than years. That is the single biggest gap in the record, because it means any statement about how long a result lasts is an extrapolation from the mechanism rather than a finding. A patient asking how long improvement will persist is asking a question the literature has not answered.

Should I trust a study paid for by the device maker?

It is not false because it is sponsored, and it is not sufficient because it is sponsored. Device-sponsored work tends to report favourable results more often, and in a field where the studies are few and small, a sponsored study may be most of the record. It should be one input rather than the whole of the basis for a decision.

Risks & Limitations

  • Plasma treatment acts on the surface of the skin. Tightening the skin is not a lift and does not reposition tissue that has descended.
  • Pigment change is the central risk. Any resurfacing injury can leave treated skin darker or lighter, and the risk is higher in skin that tans readily or marks after injury.
  • The change may settle over months and may not settle completely.
  • New collagen forms as part of healing, but the amount formed is not established as enough to change the position of the face.
  • Infection, delayed healing and a scar that heals thickly or spreads are the ordinary risks of any wound.
  • The most common disappointing outcome is not a complication: it is days of healing for a change too small to be worth them.
  • This site is an evidence review rather than a booking page, and it does not state what Chongqing West District Hospital offers in relation to plasma treatment.

When to Seek Care

  • After a resurfacing treatment, blistering, spreading redness, warmth or pus suggests infection and needs assessment.
  • A treated area that is becoming more painful rather than less, or a wound that is not closing on the expected course, needs review.
  • Any treatment close to the eye that leaves pain, a change in vision or a lid that will not close — seek emergency care immediately.
  • A treated area that heals darker or lighter than the surrounding skin should be assessed rather than treated again.
  • A fever, or a rash spreading beyond the treated area, needs medical assessment rather than cosmetic advice.

References & Further Reading

  • U.S. Food and Drug Administration (FDA) — medical device clearances and their stated intended use
  • Medicines and Healthcare products Regulatory Agency (MHRA, UK) — medical device guidance
  • National Medical Products Administration (NMPA, China) — medical device registration
  • Cochrane Library — systematic reviews on skin resurfacing and skin tightening
  • Chinese Medical Association Plastic Surgery Branch — clinical guidance

Medically reviewed by Ke He, MD (何锞), Deputy Director & Head of Skin & Laser Aesthetics. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. It is an evidence review rather than a booking page. Discuss your own case with a qualified clinician; to ask a question about the content of this review, see Contact & Consultation.